Most trauma patients with severe injuries go unscreened for drugs

Drug screening in patients with depressed GCS: An evaluation of current practice and potential bias.

Injury • • Moderately Relevant
🤖

AI Summary

This study examined how often trauma patients with severe head injuries (depressed Glasgow Coma Scale scores) underwent urine drug screening and found concerning gaps in current practice. Researchers reviewed 661 trauma patients admitted to a Level I trauma center between 2020-2022, discovering that only 39% were screened despite substance use being a major contributor to trauma severity and patient outcomes. Of those screened, an impressive 67% tested positive, revealing a significant hidden burden of substance use among this vulnerable population.

The research revealed important biases in who gets tested: patients aged 31-50 were most likely to be screened, while older patients (age 81+) and those discharged from the emergency department were significantly less likely to receive testing. Cannabis was the most commonly detected drug, appearing more frequently than other substances in positive tests. The good news is that nearly all patients with positive results were referred for SBIRT (screening, brief intervention, and referral to treatment), suggesting that when detection occurs, intervention follows promptly.

The findings highlight a critical public health gap: trauma patients with depressed consciousness are substantially under-screened despite extremely high positivity rates. This creates missed opportunities for early intervention and treatment referral among people whose substance use directly contributed to their traumatic injuries. The authors advocate for standardized screening protocols that would eliminate age and disposition biases, ensuring consistent detection and intervention across all trauma patients with impaired consciousness, regardless of demographics or discharge location."

📄 Original Abstract

Substance use contributes to trauma morbidity, mortality, and recidivism, yet screening practices among trauma patients are inconsistent. We examined urine drug screening (UDS) utilization among trauma patients presenting with depressed Glasgow Coma Scale (GCS). We retrospectively reviewed adult trauma activations (age ≥18) with admission GCS ≤ 12 at a Level I trauma center (2020-2022). The primary outcome was whether UDS was obtained. Secondary measures included demographic and clinical predictors, UDS results, and referral for screening, brief intervention, and referral to treatment (SBIRT). Logistic regression assessed associations with testing. Of 661 patients, 39% underwent UDS; 67% of these were positive. Patients aged 31-50 were more likely to be screened, while those ≥ 81 and those discharged from the emergency department were less likely. Cannabis was the most commonly detected drug. Nearly all patients with positive UDS were referred for SBIRT. Trauma patients with depressed GCS are under-screened despite high positivity. Standardized screening may improve detection and intervention.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.